Swanson, Hollie I <br/><br/>
Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Apr 2010 
 - 539-44 p.  digital 
<br/><br/> Publication Type: Congress; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-009X 
<br/><br/><label>Standard No.: </label>10.1124/dmd.109.031351  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors<br/>Carcinogens--antagonists & inhibitors<br/>Cytochrome P-450 CYP1B1<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Endothelial Cells--drug effects<br/>Enzymes--drug effects<br/>Female<br/>Humans<br/>Male<br/>Mice<br/>NF-E2-Related Factor 2--antagonists & inhibitors<br/>Neoplasms--drug therapy<br/>Pharmaceutical Preparations--metabolism<br/>Polycyclic Aromatic Hydrocarbons--antagonists & inhibitors<br/>Pregnancy<br/>Prodrugs--therapeutic use<br/>Prostatic Neoplasms--drug therapy<br/>Steroid 17-alpha-Hydroxylase--antagonists & inhibitors